Aclaris Therapeutics, Inc.
ACRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001557746
No open-market purchases or sales by Aclaris Therapeutics, Inc. insiders were filed in the last 90 days; 148 institutions reported holding it in 13F filings for Q2 2026, worth $630.0M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Aclaris Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 128
- +2 vs. Q3 2022
- Shares held
- 65.8M
- +2.23M (+3.5%) vs. Q3 2022
- Total value
- $1.04B
- +$35.7M (+3.6%) vs. Q3 2022
- New holders
- 13
- 45 more added
- Sold out
- 11
- 37 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 148 | $630.0M |
| Q1 2026 | 136 | $409.4M |
| Q4 2025 | 122 | $252.1M |
| Q3 2025 | 103 | $162.8M |
| Q2 2025 | 96 | $130.4M |
| Q1 2025 | 109 | $143.8M |
| Q4 2024 | 98 | $217.0M |
| Q3 2024 | 81 | $58.5M |
| Q2 2024 | 98 | $58.1M |
| Q1 2024 | 98 | $67.5M |
| Q4 2023 | 107 | $61.4M |
| Q3 2023 | 138 | $480.0M |
| Q2 2023 | 133 | $737.2M |
| Q1 2023 | 149 | $579.3M |
| Q4 2022 | 128 | $1.04B |
| Q3 2022 | 127 | $1.00B |
| Q2 2022 | 115 | $883.3M |
| Q1 2022 | 110 | $1.02B |
| Q4 2021 | 133 | $814.9M |
| Q3 2021 | 126 | $1.02B |
| Q2 2021 | 128 | $983.4M |
| Q1 2021 | 97 | $1.14B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Aclaris Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Aquatic Capital Management LLC | 8,800 | $139.0K | 0.01% | +8,800 | New |
| Wells Fargo & Company | 7,586 | $119.5K | 0.00% | +1,476+24.2% | Added |
| Royal Bank of Canada | 7,504 | $117.0K | 0.00% | +6,673+803.0% | Added |
| SG Americas Securities, LLC | 7,361 | $116.0K | 0.00% | −6,237−45.9% | Reduced |
| State of Wyoming | 5,533 | $87.1K | 0.03% | +5,533 | New |
| Ameritas Investment Partners, Inc. | 5,169 | $85.8K | 0.00% | +630+13.9% | Added |
| Point72 Middle East FZE | 4,788 | $75.4K | 0.01% | +4,788 | New |
| Metropolitan Life Insurance Co | 4,374 | $68.9K | 0.00% | +745+20.5% | Added |
| Amundi | 3,975 | $65.7K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2,406 | $37.9K | 0.00% | −465−16.2% | Reduced |
| Great West Life Assurance Co | 1,944 | $31.0K | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 1,881 | $30.0K | 0.00% | 00.0% | Unchanged |
| Quarry LP | 1,124 | $17.7K | 0.02% | +1,124 | New |
| Harbour Investments, Inc. | 1,000 | $15.8K | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 678 | $10.7K | 0.00% | +54+8.7% | Added |
| Tower Research Capital LLC (TRC) | 640 | $10.0K | 0.00% | −7,291−91.9% | Reduced |
| Parallel Advisors, LLC | 600 | $9.45K | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 500 | $7.88K | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 298 | $4.69K | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 248 | $4.00K | 0.00% | 00.0% | Unchanged |
| Lindbrook Capital, LLC | 208 | $3.28K | 0.00% | −31−13.0% | Reduced |
| US Bancorp | 67 | $1.05K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 93 | $1.00K | 0.00% | −879−90.4% | Reduced |
| Massmutual Trust Co FSB | 70 | $1.00K | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 61 | $961 | 0.00% | −40−39.6% | Reduced |
| Glassman Wealth Services | 16 | $252 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 16 | $0 | 0.00% | 00.0% | Unchanged |
| Covestor Ltd | 8 | $0 | 0.00% | −4−33.3% | Reduced |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −136,434−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −113,426−100.0% | Sold out |
| Requisite Capital Management, LLC | 0 | $0 | 0.00% | −45,000−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −22,536−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −18,200−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −15,950−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −13,771−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −8,109−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −1,568−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −457−100.0% | Sold out |
| Wipfli Financial Advisors LLC, | – | – | – | – | Not filed |